Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone add-on to riluzole for amyotrophic lateral sclerosis
2006-005410-13Phase 3Terminated
- Sponsor
- University Hospital Ulm
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in amyotrophic lateral sclerosis (ALS) comparing Pioglitazone + riluzole with Placebo + riluzole (2 arms). Primary endpoint: Overall survival. Started Jan 2008; status: terminated.
02
Drugs
pioglitazone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2006-005410-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005410-13.